Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
Jing‐Jing Yang, Yulu Zhou, Shuduo Xie, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 252

Showing 1-25 of 252 citing articles:

Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 474
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Shumin Sun, Jie Shen, Jianwei Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 216
Interaction between macrophages and ferroptosis
Yan Yang, Yu Wang, Lin Guo, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 210
System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
Feng‐Jiao Li, Hui‐Zhi Long, Ziwei Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 187
SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis
Lei Feng, Kaikai Zhao, Liangchao Sun, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 176
Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation
Wenchang Yang, Yaxin Wang, Chenggang Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 130
Targeting ferroptosis in acute kidney injury
Lihua Ni, Yuan Cheng, Xiaoyan Wu
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 124
Ferroptosis as a potential target for cancer therapy
Zhen Chen, Weilong Wang, Siti Razila Abdul Razak, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 101
Non-coding RNAs and ferroptosis: potential implications for cancer therapy
Amar Balihodzic, Felix Prinz, Michael A. Dengler, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1094-1106
Open Access | Times Cited: 97
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua Yu, Yue Zheng, Yiran Yao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 91
Regulatory pathways and drugs associated with ferroptosis in tumors
Dan Wang, Le Tang, Yijie Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 82
Astaxanthin attenuates osteoarthritis progression via inhibiting ferroptosis and regulating mitochondrial function in chondrocytes
Xuezhong Wang, Haohuan Li, Puji Peng, et al.
Chemico-Biological Interactions (2022) Vol. 366, pp. 110148-110148
Closed Access | Times Cited: 75
Ferroptosis in life: To be or not to be
Ling Xu, Yue Liu, Xi Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114241-114241
Open Access | Times Cited: 62
Ferroptosis and the bidirectional regulatory factor p53
Ren Xu, Wanning Wang, Wenlong Zhang
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Cardamonin alleviates chondrocytes inflammation and cartilage degradation of osteoarthritis by inhibiting ferroptosis via p53 pathway
Ziheng Gong, Yanjie Wang, Lan Li, et al.
Food and Chemical Toxicology (2023) Vol. 174, pp. 113644-113644
Closed Access | Times Cited: 55
Zooming in and out of ferroptosis in human disease
Xue Wang, Ye Zhou, Junxia Min, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 2, pp. 173-206
Closed Access | Times Cited: 52
Ferroptosis: principles and significance in health and disease
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 44
Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
Na Liu, Min‐Bin Chen
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116115-116115
Open Access | Times Cited: 43
Mechanism of sorafenib resistance associated with ferroptosis in HCC
Lingling Guo, Cuntao Hu, Mengwen Yao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 42
Ferroptosis: Mechanisms and role in diabetes mellitus and its complications
Pan Liu, Zhengdong Zhang, Yichen Cai, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102201-102201
Closed Access | Times Cited: 37
Crosstalk between metabolism and cell death in tumorigenesis
Shichao Yang, Caden Hu, Xiaomei Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization
Hanchu Xiong, Yanan Zhai, Yimei Meng, et al.
Cancer Letters (2024) Vol. 587, pp. 216732-216732
Closed Access | Times Cited: 21
Emodin induces ferroptosis in colorectal cancer through NCOA4-mediated ferritinophagy and NF-κb pathway inactivation
Zhennv Shen, Lei Zhao, Seung‐Ah Yoo, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1810-1823
Closed Access | Times Cited: 20
UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity
Chuan He, Xixin Xing, Hsin-Yi Chen, et al.
Molecular Cell (2024) Vol. 84, Iss. 6, pp. 1120-1138.e8
Open Access | Times Cited: 16
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Zixi Wang, Huaiyuan Zong, Weiwei Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top